Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Cancer Metastatic × regramostim × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 2 Stomatitis 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 Malignant Ascites 1 Lung Cancer Metastatic 1

Interventions

tremelimumab 1 regramostim 1 osimertinib 1 evolocumab 1 durvalumab 1 Surgical Instruments 1 Radiotherapy 1 Radiation 1 Nivolumab 1 Needles 1 MLN 8237 1 Ipilimumab 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03113851 2023-06-13

Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung Cancer

Peking University Cancer Hospital & Institute

Phase 2 Completed

Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡